Not finding it? Sign in to also search OpenAlex live.
-
Safety of treating acute pulmonary embolism at home: an individual patient data meta-analysis2024 European Heart Journal review Medicine Venous Thromboembolism Diagnosis and Management Open access
Dieuwke Luijten, Delphine Douillet, Kim Luijken, Cécile Tromeur, Andréa Penaloza, Olivier Hügli, +22 more
8citations -
Debio 0123-101: A phase 1 trial of Debio 0123 in combination with carboplatin in advanced solid tumors—Safety, pharmacokinetic, and preliminary antitumor activity data.
Hans A. J. Gelderblom, Mathilde Jalving, Ingrid M.E. Desar, Omar Saavedra, Jourik A. Gietema, Stefan G. van Ravensteijn, +7 more
16citations -
Working Age: Providing Occupational Safety through Pervasive Sensing and Data Driven Behavior Modeling2020 Proceedings of the 30th European Safety and Reliability Conference and 15th Probabilistic Safety Assessment and Management Conference conference-paper Computer Science Context-Aware Activity Recognition Systems Open access
Mariagrazia Fugini, Alessandro Barenghi, Sara Comai, Gerardo Pelosi, Roberto Tedesco, Marteyn van Gasteren, +12 more
12citations -
Combining Melphalan Percutaneous Hepatic Perfusion with Ipilimumab Plus Nivolumab in Advanced Uveal Melanoma: First Safety and Efficacy Data from the Phase Ib Part of the Chopin Trial2023 CardioVascular and Interventional Radiology article Medicine Ocular Oncology and Treatments Open access
Thaïs M. L. Tong, Mark Christiaan Burgmans, Frank M. Speetjens, Arian R. van Erkel, Rutger W. van der Meer, Catherina S. P. van Rijswijk, +10 more
32citations -
Safety and tolerability of nintedanib in patients with interstitial lung diseases in subgroups by sex: a post-hoc analysis of pooled data from four randomised controlled trials2022 The Lancet Rheumatology article Medicine Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Open access
Anna‐Maria Hoffmann‐Vold, Elizabeth R. Volkmann, Yannick Allanore, Shervin Assassi, Jeska Kirsten De Vries-Bouwstra, Vanessa M. Smith, +4 more
30citations -
Solriamfetol for the Treatment of Excessive Daytime Sleepiness in Participants with Narcolepsy with and without Cataplexy: Subgroup Analysis of Efficacy and Safety Data by Cataplexy Status in a Randomized Controlled Trial
Yves A Dauvilliers, Colin Michael Shapiro, Geert Mayer, Gert Jan Lammers, Hélène A. Emsellem, Giuseppe Plazzi, +5 more
18citations -
Monitoring of Adverse Events and Safety in Autoinflammatory Diseases: Real-Life Data from the Eurofever Registry2024 Journal of Clinical Immunology article Biochemistry, Genetics and Molecular Biology Inflammasome and immune disorders Open access
Yulia Vyzhga, Joost Frenkel, Antonella Insalaco, Jordi Antón, Isabelle Koné‐Paut, G. Elizabeth Legger, +16 more
4citations -
POS0050 EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH ACTIVE NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: 2-YEAR DATA FROM THE PHASE 3 SELECT-AXIS 2 STUDY2024 Annals of the Rheumatic Diseases conference-abstract Medicine Spondyloarthritis Studies and Treatments
Filip E Van den Bosch, Atul A. Deodhar, Denis Poddubnyy, Walter P. Maksymowych, Désirée M F M van der Heijde, T.-H. Kim, +7 more
0citations -
POSTER: MDS-1159: Long-Term Safety With Iptacopan Treatment in Patients With Paroxysmal Nocturnal Hemoglobinuria: Pooled Analysis of Data From Phase 2 and 3 Studies and the Roll-Over Extension Program2026 Clinical Lymphoma Myeloma & Leukemia article Immunology and Microbiology Complement system in diseases
Alexander Röth, Austin GKulasekararaj, Camilla Frieri, Flore Sicre de Fontbrune, Phillip Scheinberg, Bor‐Sheng Ko, +8 more
0citations -
Safety and tolerability of nintedanib in patients with interstitial lung diseases in subgroups by sex: a post-hoc analysis of pooled data from four randomised controlled trials2022 The Lancet Rheumatology article Medicine Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Anna‐Maria Hoffmann‐Vold, Elizabeth R. Volkmann, Yannick Allanore, Shervin Assassi, Jeska Kirsten De Vries-Bouwstra, Vanessa M. Smith, +4 more
0citations -
MDS-1159: Long-Term Safety With Iptacopan Treatment in Patients With Paroxysmal Nocturnal Hemoglobinuria: Pooled Analysis of Data From Phase 2 and 3 Studies and the Roll-Over Extension Program2026 Clinical Lymphoma Myeloma & Leukemia conference-abstract Immunology and Microbiology Complement system in diseases
Alexander Röth, Austin Gladston Kulasekararaj, Camilla Frieri, Flore Sicre de Fontbrune, Phillip Scheinberg, Bor‐Sheng Ko, +8 more
0citations